William (Wei) Cao – Founder, Chairman & CEO, Gracell, China
William Wei Cao, chairman and CEO of Gracell, shares the fascinating journey that inspired him to establish Gracell in Shanghai to tackle the four big challenges facing the global CAR-T…
Gracell Biotechnology Ltd is a clinical-stage biopharmaceutical company dedicated to discovering and developing best in class cellular therapeutics for patients suffering from haematological malignancy, a solid tumour or a degenerative disease.
Contact
12th Floor, 926 Yishan Road, Xuhui District, Shanghai, China
Tel: +86 21 64031375
Website: https://gracellbio.com/
Email: info@gracellbio.com
William Wei Cao, chairman and CEO of Gracell, shares the fascinating journey that inspired him to establish Gracell in Shanghai to tackle the four big challenges facing the global CAR-T…
The recent FDA decision to investigate the serious risk of patients developing new cancers after treatment with CAR-T therapies may have created some bad press around cell and gene therapies,…
A roundup of some of the biggest healthcare and pharma news from China, including the country’s struggle with a rampant COVID-19 outbreak and the external concern that surrounds it, China…
With proactive government support and an increasingly specialised workforce, China has become one of the leading nations in the development of Chimeric Antigen Receptor T-cell (CAR-T) therapies, along with the…
William Wei Cao, chairman and CEO of Gracell, shares the fascinating journey that inspired him to establish Gracell in Shanghai to tackle the four big challenges facing the global CAR-T…
See our Cookie Privacy Policy Here
